ERYTHROPOIETIC PROTOPORPHYRIA (EPP)

Clinical trials for ERYTHROPOIETIC PROTOPORPHYRIA (EPP) explained in plain language.

Never miss a new study

Get alerted when new ERYTHROPOIETIC PROTOPORPHYRIA (EPP) trials appear

Sign up with your email to follow new studies for ERYTHROPOIETIC PROTOPORPHYRIA (EPP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Experimental drug aims to let Sun-Sensitive patients enjoy daylight again

Symptom relief Completed

This study tested whether an investigational drug called MT-7117 could help adults with erythropoietic protoporphyria (EPP) spend more time in sunlight without developing painful skin symptoms. Over 100 participants were randomly assigned to receive either the drug or a placebo f…

Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA (EPP)

Phase: PHASE2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief

Last updated Apr 03, 2026 14:42 UTC

ERYTHROPOIETIC PROTOPORPHYRIA (EPP)

Get alerted when new ERYTHROPOIETIC PROTOPORPHYRIA (EPP) trials appear

Experimental drug aims to let Sun-Sensitive patients enjoy daylight again